Armer, J.M., & Whitman, M. (in press). Prevalence, symptoms, and self-management of breast cancer lymphedema. Lymphology.
Baron, R.H., Fey, J.V., Raboy, S., Thaler, H.T., Borgen, P.I., Temple, L.K.F., et al. (2002.) Eighteen sensations after breast cancer surgery: A comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncology Nursing Forum, 29, 651-659.
Baron, R.H., Kelvin, J.F., Bookbinder, M., Cramer, L., Borgen, P.I., & Thaler, H.T. (2000). Patients' sensations after breast cancer surgery. A pilot study. Cancer Practice, 8, 215-222.
Gerber, L., Lampert, M., Wood, C., Duncan, M., D'Angelo, T., Schain, W., et al. (1992). Comparison of pain, motion, and edema after modified radical mastectomy versus local excision with axillary dissection and radiation. Breast Cancer Research and Treatment, 21, 139-145.
Susman, E. (2002). New NCCN breast cancer guidelines: Upgrades for sentinel node biopsy and aromatase inhibitors. Oncology Times, 24(4), 26-28.
Baron, R.H., Fey, J.V., Raboy, S., Thaler, H.T., Borgen, P.I., Temple, L.K.F., et al. (2002). Eighteen sensations after breast cancer surgery: A comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncology Nursing Forum, 29, 651-659.
Baron, R.H., Kelvin, J.F., Bookbinder, M., Cramer, L., Borgen, P.I., & Thaler, H.T. (2000). Patients' sensations after breast cancer surgery: A pilot study. Cancer Practice, 8, 215-222.
Temple, L.K., Baron, R., Cody, H.S., III, Fey, J.V., Thaler, H.T., Borgen, P.I., et al. (2002). Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women. Annals of Surgical Oncology, 9, 654-662.
Champion, V.L., Rawl, S.M., & Menon, U. (2002). Population-based cancer screening. Oncology Nursing Forum, 29, 853-861.
Miller, A. (Ed.). (1985). Screening for cancer. Orlando, FL: Academic Press.
Smith, R.A., Cokkinides, V., von Eschenbach, A.C., Levin, B., Cohen, C., Runowicz, C.D., et al. (2002). American Cancer Society guidelines for the early detection of cancer. CA--A Cancer Journal for Clinicians, 52, 8-22.
U.S. Centers for Disease Control and Prevention. (2000). State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997. MMWR CDC Surveillance Summary, 49(SS-2), 1-60.
Rothman, K.J., & Greenland, S. (1998). Modern epidemiology (2nd ed.). Philadelphia: Lippincott-Raven.
Vogelstein, B., Fearon, E.R., Hamilton, S.R, Kern, S.E., Preisinger, A.C., Leppert, M., et al. (1988). Genetic alterations during colorectal-tumor development. New England Journal of Medicine, 319, 525-532.
Anderson, W.F., Guyton, K.Z., Hiatt, R.A., Vernon, S.W., Levin, B., & Hawk, E. (2002). Colorectal cancer screening for persons at average risk. Journal of the National Cancer Institute, 94, 1126-1133.
Black, W., Haggstrom, D., & Welch, H.G. (2002). All-cause mortality in randomized trials of cancer screening. Journal of the National Cancer Institute, 94, 167-173.
Winawer, S.J., Fletcher, R.H., Miller, L., Godlee, F., Stolar, M.H., Mulrow, C.D., et al. (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology, 112, 594-642______